- 4-Week # shares bought: 16,500
- 4-Week # shares sold: 1,262
- 12-Week # shares bought: 16,500
- 12-Week # shares sold: 1,262
- 24-Week # shares bought: 16,500
- 24-Week # shares sold: 1,262
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
Nasdaq-traded marijuana stocks are undervalued as investors remain skittish and the use of drugs produced by these biopharmaceutical companies have not been widely adopted.
Insys Therapeutics (INSY) stock is trading sharply higher this afternoon after receiving FDA approval for Syndros.
Trade-Ideas LLC identified Insys Therapeutics (INSY) as a pre-market mover with heavy volume candidate